United States frontotemporal
dementia market is expected to witness robust growth during the forecast period
owing to the increasing research & development activities being carried out
by drugs manufacturers for the treatment of this disease. Additionally, rising
cases of various neurological diseases such as frontotemporal dementia in the
country has compelled the government to increase the funding for R&D
activities in the healthcare sector. Further, growing geriatric population in
the country is also a major factor behind the growth of this market, as people
above 65 years of age are more prone to frontotemporal dementia. Moreover, increasing
life expectancy rate and availability of advanced care treatment centers such as
mental treatment centers and home care administrations are some other key factors,
which are fueling the growth of frontotemporal
dementia market in United States.
Frontotemporal dementia is a group
of disorders that occur when nerve cells in the frontal and temporal lobes of
the brain are lost. This causes the lobes to shrink. The disease can affect
behaviour, personality, language, and movement of the affected person. Currently,
no treatments are available to cure or slow the progression of frontotemporal
dementia, but healthcare providers may prescribe medicine to suppress symptoms.
United States frontotemporal
dementia market can be segmented based on drug class type, disease type, distribution
channel, end user and region. Based on drug class type, the market is
categorized into antidepressants and antipsychotics. Currently, the market is
witnessing demand for antidepressant drugs as they are highly effective in
minimizing the behavioral problems associated with frontotemporal dementia
owing to which, the segment is expected to dominate the market until 2025.
Based on distribution channel, United States frontotemporal dementia market is
segmented into hospital pharmacy, retail pharmacy, drug store, online pharmacy
and others. Among them the retail pharmacy segment is anticipated to undergo
high growth during the forecast period as more physicians are recommending drugs
such as antidepressants, which are easily available in these stores.
Major companies operating in United
States frontotemporal dementia market include Pfizer Inc., Novartis
Corporation, Hoffmann-La Roche, Inc., AstraZeneca Pharmaceuticals LP,
Sanofi-Aventis US LLC, Merck & Co., Inc., Alector, Inc., GlaxoSmithKline
LLC, Allergan USA, Inc., Eli Lilly and Company, Johnson & Johnson and Mylan
Pharmaceuticals, In, among others. The companies are focusing on carrying out
extensive clinical trials and R&D activities to launch novel drugs in the
market.
Years
considered for this report:
Historical Years: 2015-2018
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2021–2025
Objective of the Study:
- To analyze and forecast the market size of United
States frontotemporal dementia market.
- To forecast United States frontotemporal
dementia market based on drug
class type, disease type, distribution channel, end user, company and
regional distribution.
- To identify drivers and challenges for United
States frontotemporal dementia market.
- To examine competitive developments such as
expansions, new product launches, mergers & acquisitions etc. in United
States frontotemporal dementia market.
- To identify and analyze the profile of leading
players operating in the United States frontotemporal dementia market.
Click here to download the sample
TechSci Research performed both primary as well as
exhaustive secondary research for this study. Initially, TechSci Research
sourced a list of frontotemporal dementia companies across the country.
Subsequently, TechSci Research conducted primary research surveys with the
identified companies. While interviewing, the respondents were also enquired
about their competitors. Through this technique, TechSci Research could include
the companies which could not be identified due to the limitations of secondary
research.
TechSci
Research calculated United States frontotemporal dementia market size using a
bottom-up approach, where data for various end user industries and its
application across various product types were recorded and forecast for the
future years. TechSci Research sourced these values from the industry experts
and company representatives and externally validated through analyzing
historical data of these product types and applications for getting an
appropriate, overall market size. Various secondary sources such as company
websites, news articles, press releases, company annual reports, investor
presentations and financial reports were also used by TechSci Research.
Key Target
Audience:
- Frontotemporal dementia drug manufacturers, companies/partners,
hospital/clinics and other stakeholders
- Government bodies such as regulating
authorities and policy makers
- Organizations, industry associations, forums
and alliances related to frontotemporal dementia
- Market research and consulting firms
The study is useful in providing answers to several critical
questions that are important for the industry stakeholders such as frontotemporal
dementia drug manufacturing companies, end users etc., besides allowing them in
strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, United States frontotemporal dementia market has
been segmented into following categories, in addition to the industry trends which
have also been detailed below:
- United States Frontotemporal Dementia Market, By Drug Class Type:
- Antidepressants
- Fluoxetine
- Fluvoxamine
- Sertraline
- Paroxetine
- Citalopram
- Bupropion
- Mitrazepine
- Antipsychotics
- Olanzepine
- Quetiapine
- Ziprasidone
- Aripiprazole
- Risperidone
- Paliperidone
- United States Frontotemporal Dementia Market, By Disease Type:
- Behavior Variant
Frontotemporal Dementia (bvFTD)
- Primary
Progressive Aphasia (PPA)
- Others
- United States Frontotemporal Dementia Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Drug Store
- Online Pharmacy
- Others
- United States Frontotemporal Dementia Market, By End User:
- Hospitals
- Specialty Clinics
- Others
- United
States Frontotemporal Dementia Market, By Region:
- North-East
- Mid-West
- South
- West
Competitive Landscape
Company Profiles: Detailed analysis of the major
companies present in United States frontotemporal dementia market.
Available Customizations:
With the given market data, TechSci Research offers
customizations according to a company’s specific needs. The following
customization options are available for the report:
Company Information
- Detailed
analysis and profiling of additional market players (up to five).
Profit Margin Analysis
- Profit
margin analysis in case of direct and indirect sales channel.
It is an upcoming report to
be released soon. If you wish an early delivery of this report or want to
confirm the date of release, please contact us at [email protected]
In case you don’t find what you are looking for, please get in touch with our custom research team at [email protected]